Yahoo
NYSE - Delayed Quote USD

AptarGroup, Inc. (ATR)

137.20 +6.56 (+5.02%)
At close: October 30 at 4:00:03 PM EDT
137.20 0.00 (0.00%)
After hours: October 30 at 4:01:21 PM EDT
Trade ATR on Coinbase
ATR Q3 2026 earnings call
Replay the call for the latest insights.
Chart Range Bar
Loading chart for ATR
  • Previous Close 130.64
  • Open 138.59
  • Bid 135.93 x 10000
  • Ask 136.16 x 20000
  • Day's Range 135.52 - 142.31
  • 52 Week Range 108.29 - 146.91
  • Volume 1,007,388
  • Avg. Volume 456,634
  • Market Cap (intraday) 8.697B
  • Beta (5Y Monthly) 0.34
  • PE Ratio (TTM) 24.77
  • EPS (TTM) 5.54
  • Earnings Date Oct 29, 2026
  • Forward Dividend & Yield 2.00 (1.46%)
  • 1y Target Est 162.38
  • Morningstar Rating Rating available with Stock Picks access

AptarGroup, Inc. designs and manufactures drug delivery, consumer product dispensing, and active material science solutions and services for the pharmaceutical, fragrance, facial skincare, color cosmetics, personal care, home care, and food and beverage markets. The company operates through three segments: Pharma, Beauty, and Closures. It provides dispensing pumps used to dispense sprays, liquids, or lotions from non-pressurized containers; fine-mist pumps for pharmaceutical and fragrance applications; and lotion pumps for viscous formulations, as well as closures, such as dispensing and non-dispensing solutions that enable product delivery without removal of the cap and used across various consumer end markets. The company also offers aerosol valves used in pressurized containers and continuous spray and metered-dose valves for pharmaceutical, personal care, and household applications; elastomeric primary packaging components; active material science solutions; and digital health solutions. The company primarily sells its products and services in Asia, Europe, Latin America, and North America. AptarGroup, Inc. was incorporated in 1992 and is headquartered in Crystal Lake, Illinois.

www.aptar.com

14,000

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Performance Overview

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

ATR
13.78%
S&P 500 (^GSPC)
10.73%

1-Year Return

ATR
11.58%
S&P 500 (^GSPC)
11.11%

3-Year Return

ATR
16.36%
S&P 500 (^GSPC)
81.91%

5-Year Return

ATR
20.96%
S&P 500 (^GSPC)
64.59%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q3 FY26
Revenue 1.02B
Earnings 32.6M
Profit Margin 3.20%

Q4

FY25

Q1

FY26

Q2

FY26

Q3

FY26

0
200M
400M
600M
800M
1B
4.0%
5.0%
6.0%
7.0%
8.0%

Analyst Insights

View More

Analyst Price Targets

135.00
162.38 Average
137.20 Current
220.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Latest Rating

Date 10/9/2026
Analyst UBS
Rating Action Initiated
Rating Neutral
Price Action Announces
Price Target 135

Statistics

View More

Valuation Measures

Annual
As of 10/30/2026
  • Market Cap

    8.70B

  • Enterprise Value

    9.95B

  • Trailing P/E

    33.14

  • Forward P/E

    22.60

  • PEG Ratio (current)

    10.42

  • Price/Sales (ttm)

    2.22

  • Price/Book (mrq)

    3.33

  • Enterprise Value/Revenue

    2.49

  • Enterprise Value/EBITDA

    13.80

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    6.70%

  • Return on Assets (ttm)

    6.05%

  • Return on Equity (ttm)

    9.79%

  • Revenue (ttm)

    3.99B

  • Net Income Avi to Common (ttm)

    267.19M

  • Diluted EPS (ttm)

    5.54

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    212.3M

  • Total Debt/Equity (mrq)

    53.30%

  • Levered Free Cash Flow (ttm)

    255.67M

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Company Insights

Fair Value

137.20 Current

Dividend Score

0 Low
Sector Avg.
100 High

Hiring Score

0 Low
Sector Avg.
100 High

Insider Sentiment Score

0 Low
Sector Avg.
100 High

Research Reports

View More
  • Aptar Earnings: Headline Result Masks Excellent Underlying Margin Improvement in Pharma

    Headquartered in Crystal Lake, Illinois, AptarGroup is a leading global supplier of dispensing systems such as aerosol valves, pumps, closures, and elastomer packaging components to the consumer goods and pharmaceutical markets. Its sales are primarily from Europe (49% of sales) and the United States (28%), with China contributing 5% and other countries contributing 17%. It operates three business segments, Pharma, Beauty, and Closures. Pharma generates over two thirds of group profits.

  • Rating increased to a BUY

    APTARGROUP INC has an Investment Rating of BUY; a target price of $139.000000; an Industry Subrating of Medium; a Management Subrating of Medium; a Safety Subrating of High; a Financial Strength Subrating of Medium; a Growth Subrating of High; and a Value Subrating of High.

  • Raising target price to $119.00

    APTARGROUP INC has an Investment Rating of HOLD; a target price of $119.000000; an Industry Subrating of Medium; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of High; and a Value Subrating of Medium.

  • Despite Emergency Medicines Destocking, Aptar's Underlying Business Remains Healthy

    Headquartered in Crystal Lake, Illinois, AptarGroup is a leading global supplier of dispensing systems such as aerosol valves, pumps, closures, and elastomer packaging components to the consumer goods and pharmaceutical markets. Its sales are primarily from Europe (49% of sales) and the United States (28%), with China contributing 5% and other countries contributing 17%. It operates three business segments, Pharma, Beauty, and Closures. Pharma generates over two thirds of group profits.

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: